Epidemiology, prevention, and early detection of breast cancer
- PMID: 9370070
- DOI: 10.1097/00001622-199711000-00003
Epidemiology, prevention, and early detection of breast cancer
Abstract
Breast cancer is a leading women's health issue. Continued advances in understanding the temporal sequencing of relevant exposures promises to shed light on the continuum of breast carcinogenesis. Oral contraceptive use and the transient increase in risk following childbirth are exposures that affect the near-term risk of breast cancer. The availability of commercial testing for inherited susceptibility to breast cancer has accelerated the need for data to develop sound policy for implementing gene testing. The risks associated with BRCA1 and BRCA2 mutations may be less than previously estimated. Antiestrogens with lesser risks than tamoxifen hold promise for chemoprevention, but await testing. Not enough is known to formulate primary prevention strategies based on lifestyle interventions. Further understanding lifestyle factors that may be involved in the etiology of breast cancer and are amenable to preventive intervention thus remains a top priority, with diet and physical activity of greatest interest.
Similar articles
-
Epidemiology, prevention, and early detection of breast cancer.Curr Opin Oncol. 1996 Nov;8(6):455-61. doi: 10.1097/00001622-199611000-00003. Curr Opin Oncol. 1996. PMID: 8971464 Review.
-
Epidemiology, prevention, and early detection of breast cancer.Curr Opin Oncol. 2000 Nov;12(6):515-20. doi: 10.1097/00001622-200011000-00001. Curr Opin Oncol. 2000. PMID: 11085449 Review.
-
Epidemiology, prevention, and early detection of breast cancer.Curr Opin Oncol. 1995 Nov;7(6):489-94. doi: 10.1097/00001622-199511000-00002. Curr Opin Oncol. 1995. PMID: 8547394 Review.
-
Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations.JAMA. 2000 Feb 2;283(5):617-24. doi: 10.1001/jama.283.5.617. JAMA. 2000. PMID: 10665701
-
Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.JAMA. 2001 Nov 14;286(18):2251-6. doi: 10.1001/jama.286.18.2251. JAMA. 2001. PMID: 11710890 Clinical Trial.
Cited by
-
Molecular profiles of BRCA1-mutated and matched sporadic breast tumours: relation with clinico-pathological features.Br J Cancer. 2001 Aug 17;85(4):538-45. doi: 10.1054/bjoc.2001.1937. Br J Cancer. 2001. PMID: 11506493 Free PMC article.
-
Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform.Genes Dev. 2003 Jan 15;17(2):201-13. doi: 10.1101/gad.1050003. Genes Dev. 2003. PMID: 12533509 Free PMC article.
-
Centrosomal microtubule nucleation activity is inhibited by BRCA1-dependent ubiquitination.Mol Cell Biol. 2005 Oct;25(19):8656-68. doi: 10.1128/MCB.25.19.8656-8668.2005. Mol Cell Biol. 2005. PMID: 16166645 Free PMC article.
-
Inhibition of estrogen-dependent tumorigenesis by the thyroid hormone receptor β in xenograft models.Am J Cancer Res. 2013 Jun 20;3(3):302-11. Print 2013. Am J Cancer Res. 2013. PMID: 23841029 Free PMC article.
-
Breast self-examination in long-term breast cancer survivors.J Cancer Surviv. 2008 Dec;2(4):243-52. doi: 10.1007/s11764-008-0066-x. Epub 2008 Sep 23. J Cancer Surviv. 2008. PMID: 18810644
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous